FNA Stock Overview
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally.
Paragon 28, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$19.38|
|52 Week High||US$21.15|
|52 Week Low||US$12.35|
|1 Month Change||9.62%|
|3 Month Change||20.75%|
|1 Year Change||0.57%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||3.58%|
Recent News & Updates
|FNA||US Medical Equipment||US Market|
Return vs Industry: FNA exceeded the US Medical Equipment industry which returned -16.7% over the past year.
Return vs Market: FNA exceeded the US Market which returned -14.9% over the past year.
|FNA Average Weekly Movement||9.1%|
|Medical Equipment Industry Average Movement||8.9%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: FNA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: FNA's weekly volatility (9%) has been stable over the past year.
About the Company
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis.
Paragon 28, Inc. Fundamentals Summary
|FNA fundamental statistics|
Is FNA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|FNA income statement (TTM)|
|Cost of Revenue||US$30.74m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.43|
|Net Profit Margin||-19.24%|
How did FNA perform over the long term?See historical performance and comparison